TDVAX vaccine contraindications and precautions (Please see MassBiologics product insert for complete list):
-
- Serious allergic or hypersensitivity reaction to a previous shot, or to any diphtheria or tetanus toxoid vaccine;
- If Guillain-Barré Syndrome (GBS) occurred within six weeks of a previous tetanus toxoid vaccine, the decision to administer TDVAX should carefully examine the possible risk and benefits prior to vaccination;
- Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive TDVAX more frequently than every 10 years.
TDVAX is approved for use in adults and children seven years of age and older. TDVAX should not be administered to children younger than seven years.
